Item

104-Year-Old World War II Veteran Beats COVID-19

Title (Dublin Core)

104-Year-Old World War II Veteran Beats COVID-19

Description (Dublin Core)

This remarkable article tells the story of how a 104-year-old World War II veteran from Alabama named Major Wooten was able to beat COVID-19 in a little under two weeks after testing positive. The article describes how Major Wooten was given an infusion of a newly approved monoclonal antibody therapy named bamlanivimab, and while this treatment physically drained him temporarily, he was able to recover 24 hours later. Wooten maintains that he is still quite drained and “mentally fuzzy” after having COVID-19, but this remarkable man was able to bounce back extremely well from the disease. This article is significant to the archival collection relating to COVID-19 survivors, as well as the collection pertaining to veterans. It truly is amazing to see someone like Major Wooten survive fighting in France during World War II, and then continue to beat the odds by defeating such a deadly disease. This article will do a great job of addressing the lack of input within the archives from elderly veterans on how the COVID-19 pandemic impacted their lives.

Date (Dublin Core)

Creator (Dublin Core)

Event Identifier (Dublin Core)

Partner (Dublin Core)

Type (Dublin Core)

Text story
News article

Link (Bibliographic Ontology)

Publisher (Dublin Core)

LA Times

Controlled Vocabulary (Dublin Core)

English
English

Curator's Tags (Omeka Classic)

Contributor's Tags (a true folksonomy) (Friend of a Friend)

Collection (Dublin Core)

Linked Data (Dublin Core)

Date Submitted (Dublin Core)

03/27/2022
08/02/2022

Date Modified (Dublin Core)

03/31/2022
04/16/2022

Date Created (Dublin Core)

12/04/2020

Item sets

This item was submitted on March 27, 2022 by [anonymous user] using the form “Share Your Story” on the site “A Journal of the Plague Year”: https://covid-19archive.org/s/archive

Click here to view the collected data.

New Tags

I recognize that my tagging suggestions may be rejected by site curators. I agree with terms of use and I accept to free my contribution under the licence CC BY-SA